The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HIT | N/A | N/A | N/A | -43% |
| S&P | +13.96% | +91.24% | +13.85% | +14% |
No news articles found for Health In Tech.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $8.49M | 90.4% |
| Gross Profit | $5.36M | 54.1% |
| Gross Margin | 63.15% | -14.9% |
| Market Cap | $181.01M | 0.0% |
| Market Cap / Employee | $2.26M | 0.0% |
| Employees | 80 | -3.6% |
| Net Income | $0.45M | 20.2% |
| EBITDA | $0.71M | 23.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $8.02M | 359.2% |
| Accounts Receivable | $0.87M | -6.9% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.08M | -46.8% |
| Short Term Debt | $0.07M | 14.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 8.86% | 0.0% |
| Return On Invested Capital | 10.40% | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $1.48M | 17.0% |
| Operating Free Cash Flow | $0.67M | -43.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 431.85 | 34.28 | 36.07 | - | |
| Price to Book | 41.91 | 2.74 | 3.40 | 11.02 | - |
| Price to Sales | 15.01 | 1.69 | 1.83 | - | |
| Price to Tangible Book Value | 86.95 | 3.93 | 5.10 | 16.60 | - |
| Price to Free Cash Flow TTM | 134.39 | 11.15 | 13.60 | - | |
| Enterprise Value to EBITDA | 461.89 | 35.23 | 57.61 | - | |
| Free Cash Flow Yield | 0.7% | 9.0% | 7.4% | - | |
| Return on Equity | 7.0% | 10.5% | 11.9% | 11.9% | - |
| Total Debt | $0.21M | $0.19M | $0.17M | $0.16M | -29.10% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
